Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

28. Matching and Differential Therapies 657Carroll, K. M., Rounsaville, B. J., Gordon, L. T., Nich, C., Jatlow, P. M., Bisighini, R.M., et al. (1994). Psychotherapy and pharmacotherapy for ambulatory cocaineabusers. Arch Gen Psychiatry, 51, 177–197.Carroll, K. M., Rounsaville, B. J., Nich, C., Gordon, L. T., Wirtz, P. W., & Gawin, F. H.(1994). One year follow-up of psychotherapy and pharmacotherapy for cocainedependence: Delayed emergence of psychotherapy effects. Arch Gen Psychiatry, 51,989–997.COMBINE Study Research Group. (2003). Testing combined pharmacotherapies andbehavioral therapies in alcohol dependence: Rationale and methods. Alcohol ClinExp Res, 27, 1107–1122.Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift,B., et al. (1997). Naltrexone pharmacotherapy for opioid dependent federal probationers.J Subst Abuse Treat, 14, 529–534.Cowan, A., & Lewis, J. W. (1995). Buprenorphine: Combating drug abuse with a uniqueopioid. New York: Wiley.Crits-Christoph, P., Siqueland, L., Blaine, J. D., Frank, A., Luborsky, L., Onken, L. S.,et al. (1999). Psychosocial treatments for cocaine dependence: Results of theNational Institute on Drug Abuse Collaborative Cocaine Study. Arch Gen Psychiatry,56, 495–502.DeRubeis, R. J., & Crits-Christoph, P. (1998). Empirically supported individual andgroup psychological treatments for adult mental disorders. J Consult Clin Psychol,66, 37–52.Ehrman, R. N., Robbins, S. J., & Cornish, J. W. (2001). Results of a baseline urine testpredict levels of cocaine use during treatment. Drug Alcohol Depend, 62, 1–7.Elkin, I., Pilkonis, P. A., Docherty, J. P., & Sotsky, S. M. (1988). Conceptual andmethodologic issues in compartive studies of psychotherapy and pharmacotherapy:I. Active ingredients and mechanisms of change. Am J Psychiatry, 145, 909–917.Epstein, D. E., Hawkins, W. E., Covi, L., Umbricht, A., & Preston, K. L. (2003).Cognitive behavioral therapy plus contingency management for cocaine use:Findings during treatment and across 12-month follow-up. Psychol Addict Behav,17, 73–82.Epstein, E. E., & McCrady, B. S. (1998). Behavioral couples treatment of alcohol anddrug use disorders: Current status and innovations. Clin Psychol Rev, 18, 689–711.Fals-Stewart, W., O’Farrell, T. J., & Birchler, G. R. (1997). Behavioral couples therapyfor male substance-abusing patients: A cost outcomes analysis. J Consult ClinPsychol, 65, 789–802.Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiange, C. N., Jones, K., etal. (2003). Office-based treatment of opiate addiction with a sublingual-tablet formulationof buprenorphine and naloxone. N Engl J Med, 329(10), 949–958.Fudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990). Use of buprenorphine inthe treatment of opioid addiction: II. Physiologic and behavioral effects of dailyand alternate-day administration and abrupt withdrawal. J Pharmacol Exp Ther, 47,525–534.Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L.,et al. (1986). Disulfiram treatment of alcoholism: A Veterans Administrationcooperative study. JAMA, 256, 1449–1455.